Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American populationJARA, Lilian; GONZALEZ-HORMAZABAL, Patricio; MARGARIT, Sonia et al.Breast cancer research and treatment. 2013, Vol 137, Num 2, pp 559-569, issn 0167-6806, 11 p.Article

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trialDAVIES, Christina; HONGCHAO PAN; BRADBURY, Joan et al.Lancet (British edition). 2013, Vol 381, Num 9869, pp 805-816, issn 0140-6736, 12 p.Article

Variants in DNA double-strand break repair genes and risk of familial breast cancer in a South American populationJARA, Lilian; DUBOIS, Karen; PERALTA, Octavio et al.Breast cancer research and treatment. 2010, Vol 122, Num 3, pp 813-822, issn 0167-6806, 10 p.Article

Spectrum of BRCA1/2 point mutations and genomic rearrangements in high-risk breast/ovarian cancer Chilean familiesGONZALEZ-HORMAZABAL, Patricio; GUTIERREZ-ENRIQUEZ, Sara; DIEZ, Orland et al.Breast cancer research and treatment. 2011, Vol 126, Num 3, pp 705-716, issn 0167-6806, 12 p.Article

Increased Risk of Recurrence After Hormone Replacement Therapy in Breast Cancer SurvivorsHOLMBERG, Lars; IVERSEN, Ole-Erik; ARRIAGADA, Rodrigo et al.Journal of the National Cancer Institute. 2008, Vol 100, Num 7, pp 475-482, issn 0027-8874, 8 p.Article